Leading CFOs speak their mind on IAS39

In less than six months’ time IAS 39, one of the most controversial accounting standards to date, will hit Europe’s listed companies. There are practical implications of IAS 39 for corporates, from hedging balance sheets at a macro level to appropriately calculating the carry amount of assets, liabilities and derivatives. But how are CFOs reacting to the impending deadline? A recent report published by KPMG provides some answers.

Jon Symonds, CFO of AstraZeneca, argues UK companies are well-prepared: “Large UK companies have crossed the Rubicon,” he says. “They